BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 37454877)

  • 1. Formin-related protein 1 facilitates proliferation and aggressive phenotype of clear cell renal cell carcinoma through MAPK/MMP2 pathway.
    Ma G; Zhang B; Fu S; Lu J; Zhang L; Shang P; Yue Z
    Mol Cell Probes; 2023 Oct; 71():101921. PubMed ID: 37454877
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Downregulation of CLDN7 due to promoter hypermethylation is associated with human clear cell renal cell carcinoma progression and poor prognosis.
    Li Y; Gong Y; Ning X; Peng D; Liu L; He S; Gong K; Zhang C; Li X; Zhou L
    J Exp Clin Cancer Res; 2018 Nov; 37(1):276. PubMed ID: 30428910
    [TBL] [Abstract][Full Text] [Related]  

  • 3. G6PD facilitates clear cell renal cell carcinoma invasion by enhancing MMP2 expression through ROS‑MAPK axis pathway.
    Zhang Q; Han Q; Yang Z; Ni Y; Agbana YL; Bai H; Yi Z; Yi X; Kuang Y; Zhu Y
    Int J Oncol; 2020 Jul; 57(1):197-212. PubMed ID: 32319593
    [TBL] [Abstract][Full Text] [Related]  

  • 4. DKC1 serves as a potential prognostic biomarker for human clear cell renal cell carcinoma and promotes its proliferation, migration and invasion via the NF‑κB pathway.
    Zhang M; Pan Y; Jiang R; Hou P; Shan H; Chen F; Jiang T; Bai J; Zheng J
    Oncol Rep; 2018 Aug; 40(2):968-978. PubMed ID: 29901172
    [TBL] [Abstract][Full Text] [Related]  

  • 5. RP11-367G18.1 V2 enhances clear cell renal cell carcinoma progression via induction of epithelial-mesenchymal transition.
    Shao IH; Peng PH; Wu HH; Chen JL; Lai JC; Chang JS; Wu HT; Wu KJ; Pang ST; Hsu KW
    Cancer Med; 2023 Apr; 12(8):9788-9801. PubMed ID: 36847128
    [TBL] [Abstract][Full Text] [Related]  

  • 6. ADAM12 promotes clear cell renal cell carcinoma progression and triggers EMT via EGFR/ERK signaling pathway.
    Xu J; Wang Y; Jiang J; Yin C; Shi B
    J Transl Med; 2023 Jan; 21(1):56. PubMed ID: 36717944
    [TBL] [Abstract][Full Text] [Related]  

  • 7. RHBDD1 promotes proliferation, migration, invasion and EMT in renal cell carcinoma via the EGFR/AKT signaling pathway.
    Li M; Cai L; Wang X; Yu Y; Jian W; Bao G; Gao Z; Guo J; Zhang J; Li C; Zhang C
    Mol Med Rep; 2021 Dec; 24(6):. PubMed ID: 34581421
    [TBL] [Abstract][Full Text] [Related]  

  • 8. NCOA7 Regulates Growth and Metastasis of Clear Cell Renal Cell Carcinoma via MAPK/ERK Signaling Pathway.
    Guo J; Ke S; Chen Q; Zhou J; Guo J; Qiu T
    Int J Mol Sci; 2023 Jul; 24(14):. PubMed ID: 37511343
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MTDH promotes metastasis of clear cell renal cell carcinoma by activating SND1-mediated ERK signaling and epithelial-mesenchymal transition.
    He A; He S; Huang C; Chen Z; Wu Y; Gong Y; Li X; Zhou L
    Aging (Albany NY); 2020 Jan; 12(2):1465-1487. PubMed ID: 31978894
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MEIS1 inhibits clear cell renal cell carcinoma cells proliferation and in vitro invasion or migration.
    Zhu J; Cui L; Xu A; Yin X; Li F; Gao J
    BMC Cancer; 2017 Mar; 17(1):176. PubMed ID: 28270206
    [TBL] [Abstract][Full Text] [Related]  

  • 11. TRIM33 Overexpression Inhibits the Progression of Clear Cell Renal Cell Carcinoma In Vivo and In Vitro.
    Xu Y; Wu G; Zhang J; Li J; Ruan N; Zhang J; Zhang Z; Chen Y; Zhang Q; Xia Q
    Biomed Res Int; 2020; 2020():8409239. PubMed ID: 32908919
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hypoxia-induced overexpression of stanniocalcin-1 is associated with the metastasis of early stage clear cell renal cell carcinoma.
    Ma X; Gu L; Li H; Gao Y; Li X; Shen D; Gong H; Li S; Niu S; Zhang Y; Fan Y; Huang Q; Lyu X; Zhang X
    J Transl Med; 2015 Feb; 13():56. PubMed ID: 25740019
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High-level S100A6 promotes metastasis and predicts the outcome of T1-T2 stage in clear cell renal cell carcinoma.
    Lyu X; Li H; Ma X; Li X; Gao Y; Ni D; Shen D; Gu L; Wang B; Zhang Y; Zhang X
    Cell Biochem Biophys; 2015 Jan; 71(1):279-90. PubMed ID: 25120023
    [TBL] [Abstract][Full Text] [Related]  

  • 14. miRNA‑205‑5p functions as a tumor suppressor by negatively regulating VEGFA and PI3K/Akt/mTOR signaling in renal carcinoma cells.
    Huang J; Wang X; Wen G; Ren Y
    Oncol Rep; 2019 Nov; 42(5):1677-1688. PubMed ID: 31545453
    [TBL] [Abstract][Full Text] [Related]  

  • 15. miR-429-CRKL axis regulates clear cell renal cell carcinoma malignant progression through SOS1/MEK/ERK/MMP2/MMP9 pathway.
    Wang J; Wang C; Li Q; Guo C; Sun W; Zhao D; Jiang S; Hao L; Tian Y; Liu S; Sun MZ
    Biomed Pharmacother; 2020 Jul; 127():110215. PubMed ID: 32413671
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cyclic AMP responsive element-binding protein induces metastatic renal cell carcinoma by mediating the expression of matrix metallopeptidase-2/9 and proteins associated with epithelial-mesenchymal transition.
    Wang X; Cui H; Lou Z; Huang S; Ren Y; Wang P; Weng G
    Mol Med Rep; 2017 Jun; 15(6):4191-4198. PubMed ID: 28487942
    [TBL] [Abstract][Full Text] [Related]  

  • 17. VHL mutation-mediated SALL4 overexpression promotes tumorigenesis and vascularization of clear cell renal cell carcinoma via Akt/GSK-3β signaling.
    Sun J; Tang Q; Gao Y; Zhang W; Zhao Z; Yang F; Hu X; Zhang D; Wang Y; Zhang H; Song B; Zhang B; Wang H
    J Exp Clin Cancer Res; 2020 Jun; 39(1):104. PubMed ID: 32513235
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Overexpressed lncRNA FTX promotes the cell viability, proliferation, migration and invasion of renal cell carcinoma via FTX/miR‑4429/UBE2C axis.
    Chen Z; Zhang M; Lu Y; Ding T; Liu Z; Liu Y; Zhou Z; Wang L
    Oncol Rep; 2022 Sep; 48(3):. PubMed ID: 35866591
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Astrocyte Elevated Gene 1 (AEG-1) Acts as a Promoter Gene in Clear Cell Renal Cell Carcinoma Cell Growth and Metastasis.
    Yu DP; Zhou Y
    Med Sci Monit; 2018 Nov; 24():8213-8223. PubMed ID: 30431025
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MiR-182-5p inhibits the tumorigenesis of clear cell renal cell carcinoma by repressing UBE2T.
    Wu Y; Zhang C; Peng D; He S; Huang C; Qian J; Zhu W; Feng N; Gong Y; Li X; Zhou L
    Hum Cell; 2022 Mar; 35(2):542-556. PubMed ID: 35129808
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.